National Institute On Drug Abuse (nida)
Clinical trials sponsored by National Institute On Drug Abuse (nida), explained in plain language.
-
Could a diabetes shot curb cannabis cravings? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes, can help people with moderate to severe cannabis use disorder use less cannabis. About 100 adults will receive either the drug or a placebo, and researchers will track how many days they stay cannabis-free and any si…
Phase: PHASE2 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New brain zapping technique tested for safety in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new type of brain stimulation called high-density theta burst stimulation (hdTBS) in 35 healthy adults aged 22 to 60. The goal is to check if it is safe and to see how it affects brain activity compared to standard stimulation. Participants will hav…
Phase: PHASE1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated May 17, 2026 02:46 UTC
-
Scientists use sound waves to unlock secrets of smell
Knowledge-focused Not yet recruitingThis study aims to understand how different parts of the brain control our sense of smell and guide our behavior. Healthy adults aged 18 to 45 will undergo tasks involving odors, pictures, and sounds while researchers use ultrasound and brain scans to measure brain activity. The …
Phase: EARLY_PHASE1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC
-
First human tests begin for experimental opioid dependence drug
Knowledge-focused Not yet recruitingThis early-stage study tests a new oral drug called VK4-116 in 48 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose (or placebo) and are monitored for side effects. The study also checks if food changes how the drug works. This …
Phase: PHASE1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Kratom compound MG001 enters first human safety trial
Knowledge-focused Not yet recruitingThis early-stage study tests MG001, a compound from the kratom plant, in 32 healthy adults for the first time. The goal is to see if it is safe, how well people tolerate it, and how the body processes it. Participants receive a single dose of MG001 or a placebo and are closely mo…
Phase: PHASE1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC